Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More information22nd June 2023
EMA - Report on pharmacovigilance tasks From EU Member States
Preparedness for intensified monitoring, methodologies based on established pharmacovigilance tools as well as on innovative approaches and the flexibility and commitment of all the stakeholders involved were key factors to allow the European medicines regulatory network to effectively respond to the pandemic. These activities are detailed in a report published today.